Harvard Bioscience Takes Center Stage at Virtual Conference
In the dynamic world of life sciences, Harvard Bioscience, Inc. (Nasdaq: HBIO) is set to take the spotlight. The company has announced its participation in the upcoming Sidoti Small Cap Virtual Conference, which will take place on September 18. During this event, CEO Jim Green and CFO Jennifer Cote will present, sharing insights into the company's innovations and future plans in the life science sector.
What to Expect from the Presentation
Attendees can look forward to a live-streamed presentation, offering a chance to hear directly from the company's leadership team. These conferences play a vital role in building relationships with stakeholders and providing updates on the company's progress and achievements. Participants can anticipate an engaging discussion that showcases Harvard Bioscience’s significant contributions to research and biotechnology.
How to Access the Live Webcast
For those interested in watching the presentation, access details will be available in the investor relations section of the Harvard Bioscience website. Additionally, a replay will be provided shortly after the live event concludes, ensuring that everyone can catch up on important updates at their convenience.
About Harvard Bioscience, Inc.
Harvard Bioscience, Inc. is well-known as a leading developer and manufacturer of products that drive significant advancements in life sciences. Their offerings include essential tools for research, drug discovery, and early-stage clinical testing. With a diverse customer base that ranges from esteemed academic institutions to major pharmaceutical companies, Harvard Bioscience is a key player in the global research landscape.
Global Presence and Operations
Harvard Bioscience operates in North America, Europe, and China, utilizing both direct sales and distribution channels to serve customers around the world. Their innovative solutions cater to various applications in life science research, making meaningful contributions to biotechnology and pharmaceutical development.
Connect with Harvard Bioscience
If you would like to learn more or arrange a one-on-one meeting during the conference, it is advisable to contact the conference organizers. Additionally, for those seeking more information about Harvard Bioscience’s offerings, the company provides direct contact options.
Company Contact:
Harvard Bioscience
Jen Cote, Chief Financial Officer
(508) 893-3120
Investor Contact Information
Investors looking for further details or wishing to connect with the investor relations team can reach out to Three Part Advisors at (214) 616-2207. Email inquiries can be sent to HBIO@threepa.com.
Frequently Asked Questions
What is the Sidoti Small Cap Virtual Conference?
The Sidoti Small Cap Virtual Conference is an event that showcases innovative companies in the small-cap sector, allowing them to present their business strategies and insights directly to investors.
Who from Harvard Bioscience will be presenting?
CEO Jim Green and CFO Jennifer Cote are scheduled to present at the conference, discussing the company's strategies and innovations.
How can I watch the presentation?
The live webcast of the presentation can be accessed through the investor relations section of the Harvard Bioscience website.
Will there be a replay available?
Yes, a replay of the presentation will be made available on the company's website shortly after the live session concludes.
How can I contact Harvard Bioscience for more information?
For more information, you can reach out to Jen Cote, CFO, at (508) 893-3120, or contact their investor relations team.
